{"denoms":[{"counts":[{"groupId":"BG000","value":"321"},{"groupId":"BG001","value":"321"},{"groupId":"BG002","value":"642"}],"units":"Participants"}],"groups":[{"description":"Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.","id":"BG000","title":"Arm I"},{"description":"Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).","id":"BG001","title":"Arm II"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.7","value":"44.7"},{"groupId":"BG001","spread":"11.9","value":"44.8"},{"groupId":"BG002","spread":"12.3","value":"44.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"195"},{"groupId":"BG001","value":"170"},{"groupId":"BG002","value":"365"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"126"},{"groupId":"BG001","value":"151"},{"groupId":"BG002","value":"277"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}